OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the NIH announced nearly $290 million of new funding for seven years to research…
Alzheimer’s trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
UC Health launched clinical trials to assess antiviral drug for COVID-19
On Mar. 26, 2020, physician-scientists at four University of California Health medical centers — UC San Diego Health,…
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
The CDC reported the pace of tuberculosis decline in the U.S. slowed in recent years
On Mar. 20, 2020, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis (TB) incidence in…
Biotechnology | COVID-19 | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
University of Pennsylvania $1.5 billion Hospital Pavilion construction allowed to continue
On Mar. 20, 2020, the University of Pennsylvania announced that Pavilion project construction would be allowed to continue…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
Research on brain structure highlighted cells linked to Alzheimer’s and autism
On Mar. 16, 2020, new insights into the architecture of the brain were revealed by scientists at the…
Disease | Therapeutics | WHO
National Emergency declared in U.S. for novel Coronavirus disease outbreak
On Mar. 13, 2020, the Federal Government, along with State and local governments, announced preventive and proactive measures…
The FDA approved new treatment for adults with Cushing’s disease
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
Oregon Health Sciences doctors first to use CRISPR editing for inherited form of blindness
On Mar. 4, 2020, doctors at the Casey Eye Institute at Oregon Health & Science University in Portland…
Biotechnology | COVID-19 | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Therapeutics
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
FDA authorized marketing of first genetic test to aid in diagnosis of Fragile X Syndrome
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
Artificial Intelligence | Biotechnology | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
International collaboration generated most complete cancer genome map to date
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
BioMotiv and Bristol-Myers Squibb announced the Launch of Anteros Pharmaceuticals
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
WHO declared coronavirus outbreak a global health emergency
On Jan. 30, 2020, The WHO announced that the outbreak of a deadly and fast-spreading strain of coronavirus…
23andMe signed a strategic agreement with Almirall
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
Alexion completed acquisition of Achillion for $930 million
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
CDC published updated ACIP recommendations on the use of Td and Tdap vaccines
On Jan. 24, 2020, the Centers for Disease Control and Prevention (CDC) published updated Immunization Practices Advisory Committee…
Vanderbilt University Medical Center researchers announced new insight on diabetic retinopathy
On Jan. 23, 2020, Vanderbilt University Medical Center researchers Megan Capozzi, PhD, John Penn, PhD, and colleagues showed…
Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
Secretary Azar declared Public Health Emergency for the U.S. for 2019 Novel Coronavirus
On Jan 31, 2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency…
Medigen Vaccine Biologics completed enrollment of phase III MRCT For EV71 vaccine
On Dec. 25, 2019, Medigen Vaccine Biologics (MVB) announced it had completed the enrollment of phase III multi-region…
Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human Health Exposure Analysis Resource (HHEAR)
On Dec. 13, 2019, the Masonic Cancer Center joined the National Institute of Environmental Health Sciences Study, Human…